Sources | Names Used |
---|---|
GDSC1000 | Linifanib |
CTRPv2 | linifanib |
PharmacoGx | linifanib |
Database | Identifier |
---|---|
Smiles: | Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1 |
Pubchem: | 11485656 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CELF2 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-06 |
mRNA | ABL2 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-06 |
mRNA | TBX1 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | CST7 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | RUNX2 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | HLA-DOA | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-06 |
mRNA | HVCN1 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-06 |
mRNA | STARD8 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | CD300LB | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | C16orf74 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |